Clinical Trial Update: Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer [NA]

View source ↗

Summary

A clinical trial evaluating ferumoxytol-enhanced MRI for detecting lymph node metastases in colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Scott Potenta, MD, PhD | Conditions: Colorectal Cancer | NA | Status: WITHDRAWN